Dr Avi Spira Janssen\'s use of new technology to intercept lung cancer

Dr Avi Spira: Janssen's use of new technology to intercept lung cancer

15:59 EDT 24 Jul 2019 | Eyeforpharma

Précis: 
Dr Avi Spira, Global Head of Johnson & Johnson's Lung Cancer Initiative on their use of ML, Robotics and Molecular Technology to intercept lung cancer.
YouTube URL: 
https://www.youtube.com/watch?v=oe5T5RF1Z3E
Video Thumbnail Image: 
Channels: 
Access and Evidence
Medical
Tags: 

Original Article: Dr Avi Spira: Janssen's use of new technology to intercept lung cancer

More From BioPortfolio on "Dr Avi Spira: Janssen's use of new technology to intercept lung cancer"